AI steps in to guard cancer Patients' hearts
NCT ID NCT07191730
Summary
This study aims to develop a better tool for predicting heart damage in cancer patients receiving specific chemotherapy drugs. Researchers will use artificial intelligence (machine learning) to analyze data from 600 patients over one year. The goal is to create a score that identifies patients at highest risk, allowing doctors to monitor them more closely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Caen
RECRUITINGCaen, France
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.